<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Bronz, Gabriel</dc:creator>
  <dc:creator>Faré, Pietro B.</dc:creator>
  <dc:creator>Lava, Sebastiano A. G.</dc:creator>
  <dc:creator>Bianchetti, Mario G.</dc:creator>
  <dc:creator>Simonetti, Giacomo D.</dc:creator>
  <dc:creator>Scoglio, Martin</dc:creator>
  <dc:creator>Terziroli Beretta-Piccoli, Benedetta</dc:creator>
  <dc:creator>Agostoni, Carlo</dc:creator>
  <dc:creator>Milani, Gregorio P.</dc:creator>
  <dc:date>2022</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Coronavirus disease 2019 (COVID-19) and vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been associated with autoimmune phenomena. However, the interplay between COVID-19 or vaccination against SARS-CoV-2 and Berger glomerulonephritis or Henoch-Schönlein vasculitis, two diseases mediated by immunoglobulin A, has never been comprehensively investigated. Therefore, we carried out a systematic review of the literature on this topic. Following databases were used: Google Scholar, Excerpta Medica and the United States National Library of Medicine. Eighty-seven patients with immunoglobulin A-mediated diseases associated with SARS-CoV-2 infection or vaccination against coronavirus were sorted out (53% males, 47% females; 34 17-51 years of age, median and interquartile range): 47 cases of Berger glomerulonephritis and 40 of Henoch-Schönlein vasculitis. Approximately 50% (N = 24) of Berger glomerulonephritis and 10% (N = 4) of Henoch-Schönlein vasculitis patients presented with a pre-existing history of immunoglobulin A-mediated disease. Almost all cases of Berger glomerulonephritis were vaccine-associated (N = 44; 94%), while most cases of Henoch-Schönlein vasculitis were infection-associated (N = 23; 57%). Among vaccine-associated immunoglobulin A diseases, about 90% were associated to mRNA-based vaccines. Our analysis supports the hypothesis that COVID-19 and vaccination against SARS-CoV-2 may trigger or exacerbate an immunoglobulin A-mediated diseases.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://susi.usi.ch/global/documents/325676</dc:identifier>
  <dc:identifier>https://localhost:5000/ark:/12658/srd1325676</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/325676/files/Terziroli Beretta-Piccoli_2022_joa.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jaut.2022.102899</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1325676</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Journal of autoimmunity. - 2022, vol. 132, p. 102899</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Berger glomerulonephritis </dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Coronavirus 2019</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">COVID 19</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Henoch-schönlein vasculitis</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Immunoglobulin a nephritis</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Immunoglobulin a vasculitis</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Vaccination </dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">SARS-CoV-2</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns9="xml" ns9:lang="en">Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases : systematic literature review</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
